Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Chimin Health Management Co has the GF Score of 56, which implies that the company
might have
Poor future performance potential.
The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.
GF Score takes following five key aspects into consideration:
Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.
Based on research and backtesting result, GuruFocus believes Chimin Health Management Co
might have
Poor future performance potential.
Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.
Chimin Health Management Co (SHSE:603222) GF Score Explanation
Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:
GF Score
Performance Potential and All-in-One Screener Examples (1)
(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.
Chimin Health Management Co GF Score Related Terms
SHSE:603222 vs ISRG, BDX, MDLN: GF Score Comparison
For the Medical Instruments & Supplies subindustry, Chimin Health Management Co's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chimin Health Management Co GF Score vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Chimin Health Management Co's GF Score distribution charts can be found below:
* The bar in red indicates where Chimin Health Management Co's GF Score falls into.
Chimin Health Management Co (SHSE:603222) has a GF Score of 56 as of Aug. 01, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Chimin Health Management Co and its competitors. This is 14% below median its historical median of 65.00. Over the past decade, Chimin Health Management Co's GF Score has ranged from 12.00 to 87.00.
Is Chimin Health Management Co's GF Score too high?
Chimin Health Management Co's current GF Score of 56 is 14% below median its 10-year median of 65.00. Over the past 10 years, this metric has ranged from a low of 12.00 to a high of 87.00. Overall, Chimin Health Management Co has a GF Score™ of 56/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Chimin Health Management Co's GF Score compare to ISRG and BDX?
Chimin Health Management Co's GF Score of 56 can be compared against companies in the Medical Devices & Instruments industry. Historically, Chimin Health Management Co's own GF Score has ranged from 12.00 to 87.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Medical Devices & Instruments company?
A good GF Score depends on the Medical Devices & Instruments industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Chimin Health Management Co and its competitors. Chimin Health Management Co's current GF Score is 56, which is 14% below median its own 10-year median of 65.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chimin Health Management Co stock overvalued right now?
Based on GuruFocus' analysis, Chimin Health Management Co (SHSE:603222) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥5.89, compared to a current price of ¥7.16 — trading 21.6% above its estimated fair value. The current GF Score is 56, which is 14% below median its 10-year median of 65.00. Chimin Health Management Co's overall GF Score™ is 56/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Chimin Health Management Co (SHSE:603222), the current GF Score is 56 as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chimin Health Management Co (SHSE:603222) Overvalued in 2026?
Based on GuruFocus' analysis, Chimin Health Management Co stock appears to be overvalued.
The current stock price of ¥7.16 is trading 21.6% above its estimated GF Value™ of ¥5.89.
GuruFocus considers Chimin Health Management Co to be Modestly Overvalued.
Key valuation signals for SHSE:603222:
GF Score: 56 (14% below median its 10-year median of 65.00)
GF Value™: ¥5.89 vs. price of ¥7.16 (21.6% above fair value)
No single metric tells the full story. See the SHSE:603222 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chimin Health Management Co Ltd is engaged in the pharmaceutical industry. It is engaged in the research and development, production and sales of human medicines and medical devices. Its product centers include large volume injection, medical instruments, Nephrology treatment, and medical service. The company has production bases in Taizhou, Shanghai and Spain.
56GF Score
Get the complete analysis for SHSE:603222
GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603222 has been successfully added to your 
